Back to search

Article

A composite score based on immune-related gene prognostic index and m6A risk score of head and neck squamous cell carcinoma

2022-08-26

Abstract excerpt

<h4>Background: </h4> Immunotherapy has been demonstrated favorable in head and neck squamous cell carcinoma (HNSCC). Studies indicated that immune-related gene prognostic index (IRGPI) was a robust signature, and N6-methyladenosine (m 6 A) methylation had a significant impact on the tumor immune microenvironment (TIME) and immunotherapy of HNSCC. Thus, combining IRGPI with m 6 A status should offer a better predi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
90f5c7d8-5bc5-5c37-b3c8-46ac814d0018
DOI
10.21203/rs.3.rs-1987322/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A composite score based on immune-related gene prognostic index and m6A risk score of head and neck squamous cell carcinomaDOI 10.21203/rs.3.rs-1987322/v1
Select a neighboring publication to make it the new centre.